Publication date: May 26, 2019
Research suggests cannabis can relieve symptoms, pain associated with MS (Natural News) Multiple sclerosis (MS) is the world’s most commonly diagnosed debilitating neurological condition, and although it is most often diagnosed in young adults between the ages of 20 and 50, it can strike anyone, at any time. The National MS Society estimates that close to 1 million Americans are living with MS, with 200. .. Illegal cannabis use is common among Danes with multiple sclerosis ConclusionThis study shows that illegal cannabis use is common among Danes with MS as only 21% of the current cannabis users received prescribed cannabis-based medicine. METHODS: A literature review (Medline database and Google scholar) with no time limit was performed using keywords: “transcranial direct stimulation”, “transcranial magnetic stimulation”, “neurogenic bladder”, “urinary incontinence”, “Parkinson disease”, “multiple sclerosis”, “stroke”,. .. Functional and health promotion predictors of PROMIS(R) scores in people with multiple sclerosis. Conclusions: Findings suggest that those who report higher levels of health promotion activities and greater functional ability may experience lower levels of fatigue, pain, and sleep disturbance and higher levels of cognitive abilities in the subsequent year. (PsycINFO Database Record (c) 2019 APA, all rights reserved) Successful Treatment of Central Pain and Spasticity in Patient With Multiple Sclerosis With Dorsal Column, Paresthesia-Free Spinal Cord Stimulator: A Case Report Non-paresthesia-free spinal cord stimulation (PF-SCS) has been successfully used in treating central pain syndromes in multiple sclerosis (MS) patients. A trial and subsequent permanent placement of dorsal column spinal cord stimulator with paresthesia-free programming was successful in managing her central pain, illustrating a potential r. . Oral anticoagulants can be di. .. Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives Joseph D. Romano1,2,3,4 and Nicholas P. Tatonetti1,2,3,4* 1Department of Biomedical Informatics, Columbia University, New York, NY, United States 2Department of Systems Biology, Columbia University, New York, NY, United States 3Department of Medicine, Columbia University, New York, NY, United States 4Data Science Institute, Columbia University, New York, NY, United States The discovery of new pharmaceutical drugs is one of the preeminent tasks-scientifically, economically, and socially-in biomedical research. Effects of Neurotrophic Factors in Glial Cells in the Central Nervous System: Expression and Properties in Neurodegeneration and Injury Conclusion and Future Aspects This review summarizes available NTF expression data, compiles existing evidence on the effects of glial NTF signaling in healthy conditions and in disease models (Figure 1), and highlights the importance of this topic for future studies.
|disease||MESH||deep vein thrombosis|
- Successful Treatment of Central Pain and Spasticity in Patient With Multiple Sclerosis With Dorsal Column, Paresthesia-Free Spinal Cord Stimulator: A Case Report.
- Secondary Progressive MS and the Gut-Brain Axis
- Multiple Sclerosis: Guidelines and Palliative Care
- Intermittent vs Continuous Walking in People With Multiple Sclerosis